Interactions of ethanol with nicotine, dizocilpine, CGP 40116, and 1-(m-chlorophenyl)-biguanide in rats

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 4, 1997, Pages 1159-1165

  Bienkowski, Przemyslaw ^a,b   Koros, Eliza ^a   Piasecki, Jerzy ^a   Kostowski, Wojciech ^a,b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

1 (m Chlorophenyl) biguanide; CGP 40116; Dizocilpine; Ethanol; Locomotion; Nicotine; Rat

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; ALCOHOL; DIZOCILPINE; ION CHANNEL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SEROTONIN 3 AGONIST;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG ALCOHOL INTERACTION; DRUG EFFECT; EMBRYO; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; BEHAVIOR, ANIMAL; BIGUANIDES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DIZOCILPINE MALEATE; DRUG INTERACTIONS; ETHANOL; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0031416224     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00317-1     Document Type: Article

References (66)

1. Aracava Y., Fróes-Ferrao M. M., Perrier E. F. R., Albuquerque E. X. Sensitivity of N-methyl-D-aspartate (NMDA) and nicotinic acetylcholine receptors to ethanol and pyrazole. Ann. NY Acad. Sci. 625:1991;451-472.
2. Arneric S. P., Sullivan J. P., Williams M. Neuronal nicotinic acetylcholine receptors. Novel targets for central nervous system therapeutics Bloom F. E., Kupfer D. J. Psychopharmacology. The fourth generation of progress:1995;95-110 Raven Press, Ltd, New York.
3. Bienkowski P., Stefanski R., Kostowski W. Competitive NMDA receptor antagonist, CGP 40116 substitutes for the discriminative stimulus effects of ethanol. Eur. J. Pharmacol. 314:1996;277-280.
4. Blomqvist O., Engel J. A., Nissbrandt H., Söderpalm B. The mesolimbic dopamine-activating properties of ethanol are antagonised by mecamylamine. Eur. J. Pharmacol. 249:1993;207-213.
5. Blomqvist O., Söderpalm B., Engel J. A. Ethanol-induced locomotor activity. Involvement of central nicotinic acetylcholine receptors? Brain Res. Bull. 29:1992;173-178.
6. Breese G. R., Morrow A. L., Simson P. E., Criswell H. E., McCown T. J., Duncan G. E., Keir W. J. The neuroanatomical specificity of ethanol action on ligand-gated ion channels. A hypothesis Alcohol Alcohol. Suppl. 2:1993;309-313.
7. 3 antagonists on drug-induced dopamine release. Eur. J. Pharmacol. 164:1989;515-519.
8. Carlsson M. L., Engberg G. Ethanol behaves as an NMDA antagonist with respect to locomotor stimulation in monoamine-depleted mice. J. Neural Trasm. [Gen Sect]. 87:1992;155-160.
9. Carlsson M. L., Svensson A., Carlsson A. Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice. Naunyn Schmiedebergs Arch. Pharmacol. 343:1991;568-573.
10. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res. 543:1991;354-357.
11. Cott J. M., Carlsson J. E., Lindqvist M. Suppression of ethanol-induced locomotor stimulation by GABA-like drugs. Naunyn Schmiedebergs Arch. Pharmacol. 295:1976;203-209.
12. Crider R. Phencyclidine. Changing abuse pattern NIDA Res. Monogr. 64:1986;163-173.
13. A receptors. Generalisation to other ligand-gated ion channels J. Pharmacol. Exp. Ther. 267:1993;522-537.
14. Cummings R. O., Shaper A. G., Walker M., Wale C. J. Smoking and drinking by middle-aged British men. Effects of class and town of residence Br. Med. J. 282:1981;1497-1502.
15. Dall'Olio R., Rimondini R., Gandolfi O. The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function. Psychopharmacology (Berlin). 118:1995;310-315.
16. 2 mediated behaviors in intact rats. Psychopharmacology (Berlin). 123:1996;187-190.
17. Danysz W., Dyr W., Jankowska E., Glazewski S., Kostowski W. The involvement of NMDA receptors in acute and chronic effects of ethanol. Alcohol. Clin. Exp. Res. 16:1992;499-504.
18. de Fiebre C. M., Medhurst L. J., Collins A. C. Nicotine response and nicotinic receptors in long-sleep and short-sleep mice. Alcohol. 4:1987;493-501.
19. Dyers A. R., Stamler J., Paul O., Berkson D. M., Lepper M. H., McKean M. H., Shekelle R. B., Lindberg H. A., Garside D. Alcohol consumption, cardiovascular risk factors, and mortality in two Chicago epidemiological studies. Circulation. 56:1977;1067-1074.
20. El-Fakahany E. F., Roxanne Miller F., Abbassy M. A., Eldefrawi A. T., Eldefrawi M. E. Alcohol modulation of drug binding to the channel sites of the nicotinic acetylcholine receptor. J. Pharmacol. Exp. Ther. 224:1983;289-296.
21. French E. D., Vantini G. Noncompetitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons. Neurosci. Lett. 119:1990;159-162.
22. French E. D., Mura A., Wang T. MK 801, phecyclidine (PCP) and PCP-like drugs increase burst firing in rat A10 dopamine neurons. Comparison to competitive NMDA antagonists Synapse. 13:1993;108-116.
23. Fröhlich R., Patzelt C., Illes P. Inhibition by ethanol of excitatory amino acid receptors and nicotinic acetylcholine receptors at rat locus coeruleus neurons. Naunyn Schmiedebergs Arch. Pharmacol. 350:1994;626-631.
24. Gessa G. L., Muntoni G., Collu M., Vargiu L., Mereu G. L. Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res. 348:1985;201-203.
25. Gevaerd M. S., Takahashi R. N. Interaction of mazindol with alcohol in mice. Addict. Biol. 1:1996;303-307.
26. Gonzales R. A. NMDA receptors excite alcohol research. Trends Pharmacol. Sci. 11:1990;137-139.
27. Gordon T. L., Meehan S. M., Schechter M. D. Differential effects of nicotine but not cathinone on motor activity of P and NP rats. Pharmacol. Biochem. Behav. 44:1993;657-659.
28. Grant K. A. Emerging neurochemical concepts in the actions of ethanol at ligand-gated ion channels. Behav. Pharmacol. 5:1994;383-404.
29. Grant K. A., Colombo G. Discriminative stimulus effects of ethanol. Effect of training dose on the substitution of N-methyl-D-aspartate antagonists J. Pharmacol. Exp. Ther. 264:1993;1241-1247.
30. Imperato A., Di Chiara G. Preferential stimulation of dopa-mine release in the nucleus accumbens of freely moving rats by ethanol. J. Pharmacol. Exp. Ther. 239:1986;219-228.
31. Imperato A., Scrocco M. G., Bacchi S., Angelucci L. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. Eur. J. Pharmacol. 187:1990;555-556.
32. Istvan J., Matarazzo J. D. Tobacco, alcohol, and caffeine use. A review of their interrelationships Psychol. Bull. 95:1984;301-326.
33. 3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens. An in vivo chronocoulometric study Brain Res. 513:1990;156-160.
34. Keenan R. M., Hatsukami D. K., Pickens R. W., Gust S. W., Strelow L. J. The relationship between chronic ethanol exposure and cigarette smoking in the laboratory and the natural environment. Psychopharmacology (Berlin). 100:1990;77-83.
35. Kocchar A., Erickson C. K. Central cholinergic correlates of low dose ethanol-induced locomotor stimulation. Alcohol. Clin. Exp. Res. 10:1986;595-601.
36. Koob G. F. Neurobiological sites of drug dependence. Biol. Psychiatry. 2:1991;36-39.
37. Koob G. F. Drugs of abuse. Anatomy, pharmacology and function of reward pathways Trends Pharmacol. Sci. 13:1992;177-193.
38. 3 receptor antagonist ICS 205-930 to inhibit alcohol preference and withdrawal seizures in rats. Alcohol. 10:1993;369-373.
39. 3 receptor antagonists on ethanol-induced locomotor activity in mice. Pol. J. Pharmacol. 47:1995;293-297.
40. Kuribara H. Potentiation of the ambulation-increasing effect induced by combined administration of MK-801 with ethanol in mice. Psychopharmacology (Berlin). 113:1994;453-456.
41. Kuribara H., Asahi T., Tadokoro S. Enhancement of the ambulation-increasing effect of opioid analgesics by ethanol in mice. Jpn. J. Pharmacol. 56:1991;457-463.
42. Kuribara H., Asahi T., Tadokoro S. Ethanol enhances but diazepam and pentobarbital reduces the ambulation-increasing effect of caffeine in mice. Jpn. J. Alcohol. Drug Depend. 27:1991;528-539.
43. Liljequist S. NMDA receptor antagonists inhibit ethanol-produced locomotor stimulation in NMRI mice. Alcohol. 8:1991;309-312.
44. 3 receptors in NCB-20 cells. Alcohol. Clin. Exp. Res. 14:1990;303-314.
45. Lovinger D. M., White G., Weight F. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science. 243:1989;1721-1724.
46. Machu T. K., Harris R. A. Alcohols and anesthetics enhance the function of 5-hydroxytryptamine(3) receptors expressed in Xenopus laevis oocytes. J. Pharmacol. Exp. Ther. 271:1994;898-905.
47. Martz A., Deitrich R. A., Harris A. Behavioral evidence for the involvement of γ-aminobutyric acid in the actions of ethanol. Eur. J. Pharmacol. 89:1983;53-62.
48. Mason S. T., Corcoran M. E., Fibiger H. C. Noradrenergic processes involved in the actions of ethanol. Eur. J. Pharmacol. 54:1979;383-387.
49. Middlemiss D. N., Tricklebank M. D. Centrally active 5-HT receptor agonists and antagonists. Neurosci. Biobehav. Rev. 16:1992;75-82.
50. Plaznik A., Palejko W., Nazar M., Jessa M. Effects of antagonists at the NMDA receptor complex in two models of anxiety. Eur. Neuropsychopharmacol. 4:1994;503-512.
51. Pohorecky L. A. Biphasic actions of ethanol. Biobehav. Rev. 1:1977;231-240.
52. Robledo P., Kaneko W., Ehlers C. L. Combined effects of ethanol and MK 801 on locomotor activity in the rat. Pharmacol. Biochem. Behav. 39:1991;513-516.
53. A and NMDA receptor function in the rat. Alcohol. Clin. Exp. Res. 17:1993;115-123.
54. Schaefer G. J., Michael R. P. Interactions between alcohol and nicotine on intracranial self-stimulation and locomotor activity in rats. Drug Alcohol Depend. 30:1992;37-47.
55. Schmutz M., Portet C., Jeker A., Klebs K., Vassout A., Allgeier H., Heckendorn R., Fagg G. E., Olpe H. R., van Riesen H. The competitive NMDA receptor antagonists CGP 37849/CGP 39551 are potent, orally active anticonvulsants in rodents. Naunyn Schmiedebergs Arch. Pharmacol. 342:1990;61-66.
56. Signs S., Schechter M. D. Nicotine-induced potentiation of ethanol discrimination. Pharmacol. Biochem. Behav. 24:1986;769-771.
57. Snell L. D., Yi S.-J., Johnson K. M. Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release. Eur. J. Pharmacol. 145:1988;223-226.
58. Söderpalm B., Blomqvist O., Johnson D., Engel J. A. Involvement of central nicotinic acetylcholine receptors in the mesolimbic DA-activating and reinforcing properties of ethanol. Soc. Neurosci. Abstr. 19:1993;610.
59. 3 receptors in the mediation of the ethanol interoceptive cue. Eur. J. Pharmacol. 309:1996;141-147.
60. 3 receptor antagonist ondansetron on voluntary ethanol intake in rats and mice maintained on a limited access procedure. Psycho-pharmacology (Berlin). 117:1995;479-485.
61. Waller M. B., Murphy J. M., McBride W. J., Lumeng L., Li T.-K. Effect of low dose of ethanol on spontaneous motor activity in alcohol-preferring and -nonpreferring lines of rats. Pharmacol. Biochem. Behav. 24:1986;617-623.
62. Weiss F., Lorang M. T., Bloom F. E., Koob G. F. Alcohol self-administration stimulates dopamine release in the rat nucleus accumbens. Genetic and motivational determinants J. Pharmacol. Exp. Ther. 267:1993;250-258.
63. Wise R. A., Bozarth M. A. Actions of drugs of abuse on brain reward systems. An update with specific attention to opiates Pharmacol. Biochem. Behav. 17:1982;469-492.
64. 3 receptor attenuates the effect of ethanol on extracellular dopamine. Eur. J. Pharmacol. 187:1990;287-290.
65. Wroblewski J. T., Danysz W. Modulation of glutamate receptors. Molecular mechanisms and functional implications Annu. Rev. Pharmacol. Toxicol. 29:1989;441-447.
66. Yoshimoto K., McBride W. J., Lumeng L., Li T.-K. Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol. 9:1992;17-22.